|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1801 to 1900 out of 3295 for Kras

0.023s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Publication
First Author: Menon R
Year: 2009
Journal: Cancer Res
Title: Identification of novel alternative splice isoforms of circulating proteins in a mouse model of human pancreatic cancer.
Volume: 69
Issue: 1
Pages: 300-9
Publication
First Author: Kersemans V
Year: 2017
Journal: PLoS One
Title: An efficient and robust MRI-guided radiotherapy planning approach for targeting abdominal organs and tumours in the mouse.
Volume: 12
Issue: 4
Pages: e0176693
Publication
First Author: Baird JR
Year: 2017
Journal: PLoS One
Title: STING expression and response to treatment with STING ligands in premalignant and malignant disease.
Volume: 12
Issue: 11
Pages: e0187532
Publication
First Author: Lakshmanan I
Year: 2022
Journal: Oncogene
Title: Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma.
Volume: 41
Issue: 48
Pages: 5147-5159
Publication
First Author: Davies CC
Year: 2014
Journal: Cancer Res
Title: Impaired JNK signaling cooperates with KrasG12D expression to accelerate pancreatic ductal adenocarcinoma.
Volume: 74
Issue: 12
Pages: 3344-56
Publication
First Author: Husain K
Year: 2013
Journal: Cancer Prev Res (Phila)
Title: Vitamin E δ-tocotrienol prolongs survival in the LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre (KPC) transgenic mouse model of pancreatic cancer.
Volume: 6
Issue: 10
Pages: 1074-83
Publication
First Author: Schniers BK
Year: 2022
Journal: Biochem J
Title: Deletion of Slc6a14 reduces cancer growth and metastatic spread and improves survival in KPC mouse model of spontaneous pancreatic cancer.
Volume: 479
Issue: 5
Pages: 719-730
Publication
First Author: Schultz MJ
Year: 2016
Journal: Cancer Res
Title: The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype.
Volume: 76
Issue: 13
Pages: 3978-88
Publication
First Author: Dosch JS
Year: 2015
Journal: Cancer Res
Title: Cancer stem cell marker phenotypes are reversible and functionally homogeneous in a preclinical model of pancreatic cancer.
Volume: 75
Issue: 21
Pages: 4582-92
Publication  
First Author: Zhang Z
Year: 2020
Journal: Front Immunol
Title: Treatment and Prevention of Lung Cancer Using a Virus-Infected Reprogrammed Somatic Cell-Derived Tumor Cell Vaccination (VIReST) Regime.
Volume: 11
Pages: 1996
Publication
First Author: Haston S
Year: 2023
Journal: Cancer Cell
Title: Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer.
Volume: 41
Issue: 7
Pages: 1242-1260.e6
Publication  
First Author: Li C
Year: 2019
Journal: Front Physiol
Title: MSP-RON Signaling Is Activated in the Transition From Pancreatic Intraepithelial Neoplasia (PanIN) to Pancreatic Ductal Adenocarcinoma (PDAC).
Volume: 10
Pages: 147
Publication
First Author: Jacobson R
Year: 2024
Journal: Sci Rep
Title: Differential extracellular vesicle concentration and their biomarker expression of integrin α(v)/β(5), EpCAM, and glypican-1 in pancreatic cancer models.
Volume: 14
Issue: 1
Pages: 14273
Publication
First Author: Kaune T
Year: 2023
Journal: iScience
Title: Gender-specific changes of the gut microbiome correlate with tumor development in murine models of pancreatic cancer.
Volume: 26
Issue: 6
Pages: 106841
Publication
First Author: Jiang S
Year: 2017
Journal: Biochem Biophys Res Commun
Title: Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer.
Volume: 494
Issue: 1-2
Pages: 113-119
Publication
First Author: Patra KC
Year: 2013
Journal: Cancer Cell
Title: Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer.
Volume: 24
Issue: 2
Pages: 213-228
Publication
First Author: Maity G
Year: 2018
Journal: J Biol Chem
Title: The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.
Volume: 293
Issue: 12
Pages: 4334-4349
Publication
First Author: Solan JL
Year: 2021
Journal: Oncogene
Title: Cx43 phosphorylation sites regulate pancreatic cancer metastasis.
Volume: 40
Issue: 10
Pages: 1909-1920
Publication
First Author: Pushalkar S
Year: 2018
Journal: Cancer Discov
Title: The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression.
Volume: 8
Issue: 4
Pages: 403-416
Publication
First Author: Singh A
Year: 2009
Journal: Cancer Cell
Title: A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival.
Volume: 15
Issue: 6
Pages: 489-500
Publication
First Author: Colvin EK
Year: 2011
Journal: PLoS One
Title: Retinoid signaling in pancreatic cancer, injury and regeneration.
Volume: 6
Issue: 12
Pages: e29075
Publication
First Author: Wang Z
Year: 2011
Journal: PLoS One
Title: Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathways.
Volume: 6
Issue: 6
Pages: e20537
Publication
First Author: Nimmakayala RK
Year: 2021
Journal: Oncogene
Title: Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
Volume: 40
Issue: 1
Pages: 215-231
Publication  
First Author: Schneider P
Year: 2015
Journal: Nat Commun
Title: Identification of a novel actin-dependent signal transducing module allows for the targeted degradation of GLI1.
Volume: 6
Pages: 8023
Publication
First Author: Wang Z
Year: 2012
Journal: PLoS One
Title: Temporal dissection of K-ras(G12D) mutant in vitro and in vivo using a regulatable K-ras(G12D) mouse allele.
Volume: 7
Issue: 5
Pages: e37308
Publication
First Author: Carapuça EF
Year: 2016
Journal: J Pathol
Title: Anti-stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma.
Volume: 239
Issue: 3
Pages: 286-96
Publication  
First Author: Rahn S
Year: 2018
Journal: Cancer Lett
Title: Diabetes as risk factor for pancreatic cancer: Hyperglycemia promotes epithelial-mesenchymal-transition and stem cell properties in pancreatic ductal epithelial cells.
Volume: 415
Pages: 129-150
Publication
First Author: Halbrook CJ
Year: 2019
Journal: Cell Metab
Title: Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer.
Volume: 29
Issue: 6
Pages: 1390-1399.e6
Publication  
First Author: Chaudhary S
Year: 2021
Journal: Cancer Lett
Title: Dual blockade of EGFR and CDK4/6 delays head and neck squamous cell carcinoma progression by inducing metabolic rewiring.
Volume: 510
Pages: 79-92
Publication
First Author: Lee YS
Year: 2013
Journal: Cancer Cell
Title: Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma.
Volume: 24
Issue: 5
Pages: 603-16
Publication
First Author: Cook N
Year: 2012
Journal: J Exp Med
Title: Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma.
Volume: 209
Issue: 3
Pages: 437-44
Publication  
First Author: Natarajan V
Year: 2022
Journal: Cancers (Basel)
Title: Acquired αSMA Expression in Pericytes Coincides with Aberrant Vascular Structure and Function in Pancreatic Ductal Adenocarcinoma.
Volume: 14
Issue: 10
Publication
First Author: Lakshmanan I
Year: 2021
Journal: Mol Oncol
Title: ST6GalNAc-I promotes lung cancer metastasis by altering MUC5AC sialylation.
Volume: 15
Issue: 7
Pages: 1866-1881
Publication
First Author: Yang J
Year: 2019
Journal: Am J Cancer Res
Title: Dendritic cell immunotherapy induces anti-tumor effect in a transgenic mouse model of pancreatic ductal adenocarcinoma.
Volume: 9
Issue: 11
Pages: 2456-2468
Publication
First Author: Neesse A
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer.
Volume: 110
Issue: 30
Pages: 12325-30
Publication
First Author: Mendez R
Year: 2020
Journal: Carcinogenesis
Title: Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer.
Volume: 41
Issue: 5
Pages: 561-570
Publication
First Author: Oliver TG
Year: 2011
Journal: Mol Cell
Title: Caspase-2-mediated cleavage of Mdm2 creates a p53-induced positive feedback loop.
Volume: 43
Issue: 1
Pages: 57-71
Publication
First Author: Morton JP
Year: 2010
Journal: Gastroenterology
Title: Dasatinib inhibits the development of metastases in a mouse model of pancreatic ductal adenocarcinoma.
Volume: 139
Issue: 1
Pages: 292-303
Publication
First Author: Ferro R
Year: 2018
Journal: Oncogene
Title: GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine.
Volume: 37
Issue: 49
Pages: 6368-6382
Publication  
First Author: Lee JW
Year: 2016
Journal: Curr Protoc Pharmacol
Title: Genetically Engineered Mouse Models of Pancreatic Cancer: The KPC Model (LSL-Kras(G12D/+) ;LSL-Trp53(R172H/+) ;Pdx-1-Cre), Its Variants, and Their Application in Immuno-oncology Drug Discovery.
Volume: 73
Pages: 14.39.1-14.39.20
Publication
First Author: Popis MC
Year: 2018
Journal: BMC Res Notes
Title: Considerations for skin carcinogenesis experiments using inducible transgenic mouse models.
Volume: 11
Issue: 1
Pages: 67
Publication
First Author: Ferguson FM
Year: 2020
Journal: Nat Chem Biol
Title: Discovery of a selective inhibitor of doublecortin like kinase 1.
Volume: 16
Issue: 6
Pages: 635-643
Publication
First Author: Burrack AL
Year: 2019
Journal: Cell Rep
Title: Combination PD-1 and PD-L1 Blockade Promotes Durable Neoantigen-Specific T Cell-Mediated Immunity in Pancreatic Ductal Adenocarcinoma.
Volume: 28
Issue: 8
Pages: 2140-2155.e6
Publication
First Author: Rodríguez-Merced NJ
Year: 2023
Journal: STAR Protoc
Title: Protocol to culture and image pancreatic ductal adenocarcinoma tumor slices to study T cell migration.
Volume: 4
Issue: 1
Pages: 102135
Publication
First Author: Wang D
Year: 2017
Journal: Cancer Res
Title: CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer.
Volume: 77
Issue: 13
Pages: 3655-3665
Publication
First Author: Justilien V
Year: 2017
Journal: Cancer Cell
Title: Ect2-Dependent rRNA Synthesis Is Required for KRAS-TRP53-Driven Lung Adenocarcinoma.
Volume: 31
Issue: 2
Pages: 256-269
Publication
First Author: Crittenden MR
Year: 2018
Journal: Sci Rep
Title: Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity.
Volume: 8
Issue: 1
Pages: 7012
Publication
First Author: Qiao S
Year: 2020
Journal: Genes Dev
Title: REDD1 loss reprograms lipid metabolism to drive progression of RAS mutant tumors.
Volume: 34
Issue: 11-12
Pages: 751-766
Publication  
First Author: Salaymeh Y
Year: 2020
Journal: Life Sci Alliance
Title: Vav1 and mutant K-Ras synergize in the early development of pancreatic ductal adenocarcinoma in mice.
Volume: 3
Issue: 5
Publication
First Author: Chugh S
Year: 2018
Journal: Gastroenterology
Title: Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice.
Volume: 155
Issue: 5
Pages: 1608-1624
Publication
First Author: Davidson SM
Year: 2017
Journal: Nat Med
Title: Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors.
Volume: 23
Issue: 2
Pages: 235-241
Publication  
First Author: Verma RK
Year: 2016
Journal: Sci Rep
Title: α-Mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (Kras(G12D), and Kras(G12D)/tp53R270H) mice.
Volume: 6
Pages: 32743
Publication  
First Author: Gong L
Year: 2021
Journal: Cancer Lett
Title: DEPTOR inhibits lung tumorigenesis by inactivating the EGFR-mTOR signals.
Volume: 519
Pages: 263-276
Publication
First Author: Faca VM
Year: 2008
Journal: PLoS Med
Title: A mouse to human search for plasma proteome changes associated with pancreatic tumor development.
Volume: 5
Issue: 6
Pages: e123
Publication
First Author: Boj SF
Year: 2015
Journal: Cell
Title: Organoid models of human and mouse ductal pancreatic cancer.
Volume: 160
Issue: 1-2
Pages: 324-38
Publication
First Author: Shin J
Year: 2014
Journal: Cancer Lett
Title: A single extra copy of Dscr1 improves survival of mice developing spontaneous lung tumors through suppression of tumor angiogenesis.
Volume: 342
Issue: 1
Pages: 70-81
Publication
First Author: Frese KK
Year: 2012
Journal: Cancer Discov
Title: nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer.
Volume: 2
Issue: 3
Pages: 260-269
Publication
First Author: Dauer P
Year: 2018
Journal: Cancer Res
Title: Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression.
Volume: 78
Issue: 5
Pages: 1321-1333
Publication
First Author: Pietrocola F
Year: 2016
Journal: Cancer Cell
Title: Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance.
Volume: 30
Issue: 1
Pages: 147-160
Publication
First Author: Miller BW
Year: 2015
Journal: EMBO Mol Med
Title: Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy.
Volume: 7
Issue: 8
Pages: 1063-76
Publication
First Author: Kelly-Spratt KS
Year: 2011
Journal: PLoS One
Title: Plasma proteome profiles associated with inflammation, angiogenesis, and cancer.
Volume: 6
Issue: 5
Pages: e19721
Publication
First Author: Leca J
Year: 2016
Journal: J Clin Invest
Title: Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness.
Volume: 126
Issue: 11
Pages: 4140-4156
Publication
First Author: Dugnani E
Year: 2018
Journal: Carcinogenesis
Title: Four-class tumor staging for early diagnosis and monitoring of murine pancreatic cancer using magnetic resonance and ultrasound.
Volume: 39
Issue: 9
Pages: 1197-1206
Publication  
First Author: Cortes E
Year: 2019
Journal: EMBO Rep
Title: GPER is a mechanoregulator of pancreatic stellate cells and the tumor microenvironment.
Volume: 20
Issue: 1
Publication
First Author: Kaistha BP
Year: 2016
Journal: Cancer Res
Title: PLAC8 Localizes to the Inner Plasma Membrane of Pancreatic Cancer Cells and Regulates Cell Growth and Disease Progression through Critical Cell-Cycle Regulatory Pathways.
Volume: 76
Issue: 1
Pages: 96-107
Publication
First Author: Filippini D
Year: 2019
Journal: Sci Rep
Title: Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease.
Volume: 9
Issue: 1
Pages: 12286
Publication
First Author: Hein AL
Year: 2016
Journal: Cancer Res
Title: PR55α Subunit of Protein Phosphatase 2A Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signaling.
Volume: 76
Issue: 8
Pages: 2243-2253
Publication    
First Author: Sullivan MR
Year: 2019
Journal: Elife
Title: Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability.
Volume: 8
Publication
First Author: Zandvakili I
Year: 2015
Journal: PLoS One
Title: Loss of RhoA Exacerbates, Rather Than Dampens, Oncogenic K-Ras Induced Lung Adenoma Formation in Mice.
Volume: 10
Issue: 6
Pages: e0127923
Publication
First Author: Low RRJ
Year: 2023
Journal: Cell Death Differ
Title: S100 family proteins are linked to organoid morphology and EMT in pancreatic cancer.
Volume: 30
Issue: 5
Pages: 1155-1165
Publication
First Author: Xia Y
Year: 2012
Journal: Nat Cell Biol
Title: Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model.
Volume: 14
Issue: 3
Pages: 257-65
Publication
First Author: Lee JC
Year: 2013
Journal: Biochem Biophys Res Commun
Title: Trisomy of the Dscr1 gene suppresses early progression of pancreatic intraepithelial neoplasia driven by oncogenic Kras.
Volume: 440
Issue: 1
Pages: 50-5
Publication
First Author: Dominguez CX
Year: 2020
Journal: Cancer Discov
Title: Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy.
Volume: 10
Issue: 2
Pages: 232-253
Publication
First Author: Öhlund D
Year: 2017
Journal: J Exp Med
Title: Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer.
Volume: 214
Issue: 3
Pages: 579-596
Publication
First Author: Gocheva V
Year: 2017
Journal: Proc Natl Acad Sci U S A
Title: Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival.
Volume: 114
Issue: 28
Pages: E5625-E5634
Publication
First Author: Chugh R
Year: 2012
Journal: Sci Transl Med
Title: A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer.
Volume: 4
Issue: 156
Pages: 156ra139
Publication
First Author: Raj N
Year: 2022
Journal: Mol Cell
Title: The Mettl3 epitranscriptomic writer amplifies p53 stress responses.
Volume: 82
Issue: 13
Pages: 2370-2384.e10
Publication
First Author: Ischenko I
Year: 2014
Journal: Cell Death Differ
Title: Transforming growth factor-beta signaling network regulates plasticity and lineage commitment of lung cancer cells.
Volume: 21
Issue: 8
Pages: 1218-28
Publication
First Author: Cao S
Year: 2022
Journal: Theranostics
Title: Glutamine is essential for overcoming the immunosuppressive microenvironment in malignant salivary gland tumors.
Volume: 12
Issue: 13
Pages: 6038-6056
Publication
First Author: Merle N
Year: 2022
Journal: Mol Cancer
Title: Monitoring autochthonous lung tumors induced by somatic CRISPR gene editing in mice using a secreted luciferase.
Volume: 21
Issue: 1
Pages: 191
Publication  
First Author: Cortez NE
Year: 2023
Journal: Int J Mol Sci
Title: A Ketogenic Diet in Combination with Gemcitabine Mitigates Pancreatic Cancer-Associated Cachexia in Male and Female KPC Mice.
Volume: 24
Issue: 13
Publication
First Author: Su HT
Year: 2013
Journal: Mol Cancer Res
Title: Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
Volume: 11
Issue: 7
Pages: 768-79
Publication
First Author: Novo D
Year: 2018
Journal: Nat Commun
Title: Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levels.
Volume: 9
Issue: 1
Pages: 5069
Publication
First Author: Hu T
Year: 2021
Journal: Gastroenterology
Title: Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression.
Volume: 161
Issue: 5
Pages: 1584-1600
Publication
First Author: Gouirand V
Year: 2022
Journal: EMBO J
Title: Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression.
Volume: 41
Issue: 9
Pages: e110466
Publication
First Author: Ireland L
Year: 2016
Journal: Cancer Res
Title: Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors.
Volume: 76
Issue: 23
Pages: 6851-6863
Publication
First Author: Johnson L
Year: 2013
Journal: J Clin Invest
Title: Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy.
Volume: 123
Issue: 9
Pages: 3997-4009
Publication
First Author: Su Y
Year: 2016
Journal: Oncogene
Title: N-cadherin functions as a growth suppressor in a model of K-ras-induced PanIN.
Volume: 35
Issue: 25
Pages: 3335-41
Publication
First Author: Araki O
Year: 2023
Journal: Oncogene
Title: Brg1 controls stemness and metastasis of pancreatic cancer through regulating hypoxia pathway.
Volume: 42
Issue: 26
Pages: 2139-2152
Publication
First Author: Sanclemente M
Year: 2021
Journal: Cancer Cell
Title: RAF1 kinase activity is dispensable for KRAS/p53 mutant lung tumor progression.
Volume: 39
Issue: 3
Pages: 294-296
Publication
First Author: Liang S
Year: 2009
Journal: PLoS One
Title: Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation.
Volume: 4
Issue: 1
Pages: e4295
Publication
First Author: Du T
Year: 2019
Journal: Nat Commun
Title: The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis.
Volume: 10
Issue: 1
Pages: 2914
Publication      
First Author: Peng F
Year: 2024
Journal: Cell Metab
Title: Oncogenic fatty acid oxidation senses circadian disruption in sleep-deficiency-enhanced tumorigenesis.
Publication
First Author: Nie G
Year: 2024
Journal: Biochim Biophys Acta Gen Subj
Title: DHX33 mediates p53 to regulate mevalonate pathway gene transcription in human cancers.
Volume: 1868
Issue: 3
Pages: 130547
Publication
First Author: Zheng QW
Year: 2022
Journal: Oncogene
Title: PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3.
Volume: 41
Issue: 36
Pages: 4244-4256
Publication
First Author: Puranam KL
Year: 1995
Journal: Genomics
Title: Chromosomal localization of the gene encoding the human DNA helicase RECQL and its mouse homologue.
Volume: 26
Issue: 3
Pages: 595-8
Publication
First Author: Muñoz DM
Year: 2013
Journal: Glia
Title: Loss of p53 cooperates with K-ras activation to induce glioma formation in a region-independent manner.
Volume: 61
Issue: 11
Pages: 1862-72
Publication
First Author: Arima K
Year: 2019
Journal: Oncogene
Title: Inhibition of 15-PGDH causes Kras-driven tumor expansion through prostaglandin E2-ALDH1 signaling in the pancreas.
Volume: 38
Issue: 8
Pages: 1211-1224
Publication  
First Author: Hamada S
Year: 2021
Journal: Int J Mol Sci
Title: Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition.
Volume: 22
Issue: 4
Publication
First Author: Best SA
Year: 2020
Journal: Cell Death Dis
Title: Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis.
Volume: 11
Issue: 10
Pages: 877